Metraipolis › archive › dc_72afc360a2ce
Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40904494
- DOI
- 10.3389/fonc.2025.1617743
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:23:43.254Z
- SHA-256 of the archived text
fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c- Stable URL of this page
https://metraipolis.com/documento/dc_72afc360a2ce
How to cite
Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494 — Europe PMC (en), https://europepmc.org/article/MED/40904494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72afc360a2ce (Metraipolis archive dc_72afc360a2ce, sha256 fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c)
BibTeX
@misc{dc72afc360a2ce,
title = {Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40904494},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72afc360a2ce; sha256 fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904494. Agents can read the archived copy with the MCP tool read_document.